[Effect of splenin and zymosan on the immune system of patients with a soft tissue sarcoma].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000379:methods; D006801:Humans; D007107:Immune System / Q000187:drug effects*; D007167:Immunotherapy / Q000379:methods; D007372:Interferons / Q000097:blood; D011300:Preoperative Care / Q000379:methods; D012509:Sarcoma / Q000276:immunology / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000276:immunology / Q000628:therapy*; D013946:Thymopoietins / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*; D013997:Time Factors; D015054:Zymosan / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D013946:Thymopoietins; D013951:Thymus Hormones; C032841:thymopoietin III; D007372:Interferons; D015054:Zymosan
Vliianie splenina izimozana na immunuiu sistemu bol'nykh sarkomoĭ miagkikh tkaneĭ.